Crossref
EE78 FIRST-YEAR COST PER RESPONDER FOR BRODALUMAB COMPARED WITH OTHER BIOLOGIC THERAPIES FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN CANADA
Value in Health · 2026-06 · 29 (6) · S77
DOI: 10.1016/j.jval.2026.03.307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Julie Poulin und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Poulin, J., & Barbeau, M. (2026). EE78 FIRST-YEAR COST PER RESPONDER FOR BRODALUMAB COMPARED WITH OTHER BIOLOGIC THERAPIES FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN CANADA. Value in Health, 29(6), S77. https://doi.org/10.1016/j.jval.2026.03.307
Vancouver
Poulin J, Barbeau M. EE78 FIRST-YEAR COST PER RESPONDER FOR BRODALUMAB COMPARED WITH OTHER BIOLOGIC THERAPIES FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN CANADA. Value in Health. 2026;29(6):S77. doi:10.1016/j.jval.2026.03.307
BibTeX
@article{Poulin2026,
author = {Poulin, Julie and Barbeau, Martin},
title = {EE78 FIRST-YEAR COST PER RESPONDER FOR BRODALUMAB COMPARED WITH OTHER BIOLOGIC THERAPIES FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN CANADA},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S77},
doi = {10.1016/j.jval.2026.03.307}
}
EUVIMED